a2 Milk reports double-digit revenue growth in FY2026, full-category innovation drives new growth

Summary

a2 Milk released its FY2026 results on 17 August, reporting revenue of NZ$10.20 billion, an increase of 12.4 percent year-on-year. Underlying EBITDA rose 5.4 percent to NZ$307.6 million, while net profit after tax grew 7.0 percent to NZ$235.8 million. Revenue from China and other Asian regions increased 11.2 percent to NZ$1.4476 billion, North America grew 28.6 percent, and Australia/New Zealand rose 10.2 percent.

Whole-family nutrition products saw revenue surge 59.9 percent, with new products contributing more than 50 percent of sales growth. The company plans its largest-ever product launch in the first half of FY2027.

Commentary

a2 has steered clear of commodity competition by differentiating on A2 protein, a strategy that has paid off with China accounting for 73 percent of revenue. Meanwhile, North America's 28.6 percent growth helps diversify risk. The 59.9 percent jump in whole-family nutrition reflects rising demand tied to ageing populations, and New Zealand SMEs could look to high-value segments for similar opportunities.

However, falling newborn numbers in China and domestic substitution remain headwinds, and whether the largest-ever new product cycle can sustain premiums is yet to be seen. SMEs should take note of the premium niche strategy and carefully assess cross-border compliance costs.

Keywords: a2 Milk, FY2026, revenue growth, infant formula, whole-family nutrition, liquid milk, New Zealand dollar, results release, new product plan

Summary in Chinese | 摘要

a2公司8月17日发布2026财年业绩：营收10.20亿新西兰元，同比增12.4%；基础EBITDA 3.076亿，增5.4%；税后净利2.358亿，增7.0%。中国及其他亚洲地区营收增11.2%至14.476亿，北美增28.6%，澳新增10.2%。全家营养产品营收增59.9%，新产品贡献销售额增长50%以上，公司计划2027上半财年推出史上最大规模新品。

Commentary in Chinese | 评论

a2以A2蛋白差异化避开大宗竞争，中国区占营收73%，北美增28.6%分散风险。全家营养增59.9%反映老龄化需求，NZ SME可关注高附加值细分。但中国新生儿下降和国产替代是风险，其史上最大新品周期能否维持溢价待观察。

中小企业应借鉴高端细分策略，评估跨境合规成本。

关键词: a2牛奶公司, 2026财年, 营收增长, 婴配粉, 全家营养, 液态奶, 新西兰元, 业绩发布, 新品计划

Source: Sina News